Table of Content

1 Bio-pharma Market Overview
1.1 Bio-pharma Product Overview
1.2 Bio-pharma Market Segment by Type
1.2.1 Monoclonal Antibodies
1.2.2 Recombinant Proteins
1.2.3 Granulocyte-Colony Stimulating Factor (G-CSF)
1.2.4 Interferons
1.2.5 Recombinant Human Insulin
1.2.6 Erythropoietin
1.2.7 Vaccines
1.2.8 Growth Hormones
1.2.9 Purified Proteins
1.2.10 Others
1.3 Global Bio-pharma Market Size by Type
1.3.1 Global Bio-pharma Market Size Overview by Type (2018-2034)
1.3.2 Global Bio-pharma Historic Market Size Review by Type (2018-2024)
1.3.3 Global Bio-pharma Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Bio-pharma Sales Breakdown by Type (2018-2024)
1.4.2 Europe Bio-pharma Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Bio-pharma Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Bio-pharma Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Bio-pharma Sales Breakdown by Type (2018-2024)
2 Global Bio-pharma Market Competition by Company
2.1 Global Top Players by Bio-pharma Sales (2018-2024)
2.2 Global Top Players by Bio-pharma Revenue (2018-2024)
2.3 Global Top Players by Bio-pharma Price (2018-2024)
2.4 Global Top Manufacturers Bio-pharma Manufacturing Base Distribution, Sales Area, Product Type
2.5 Bio-pharma Market Competitive Situation and Trends
2.5.1 Bio-pharma Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Bio-pharma Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Bio-pharma as of 2022)
2.7 Date of Key Manufacturers Enter into Bio-pharma Market
2.8 Key Manufacturers Bio-pharma Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Bio-pharma Status and Outlook by Region
3.1 Global Bio-pharma Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Bio-pharma Historic Market Size by Region
3.2.1 Global Bio-pharma Sales in Volume by Region (2018-2024)
3.2.2 Global Bio-pharma Sales in Value by Region (2018-2024)
3.2.3 Global Bio-pharma Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Bio-pharma Forecasted Market Size by Region
3.3.1 Global Bio-pharma Sales in Volume by Region (2024-2034)
3.3.2 Global Bio-pharma Sales in Value by Region (2024-2034)
3.3.3 Global Bio-pharma Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Bio-pharma by Application
4.1 Bio-pharma Market Segment by Application
4.1.1 Metabolic Disorders
4.1.2 Oncology
4.1.3 Neurological Disorders
4.1.4 Cardiovascular Diseases
4.1.5 Inflammatory and Infectious Diseases
4.1.6 Others
4.2 Global Bio-pharma Market Size by Application
4.2.1 Global Bio-pharma Market Size Overview by Application (2018-2034)
4.2.2 Global Bio-pharma Historic Market Size Review by Application (2018-2024)
4.2.3 Global Bio-pharma Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Bio-pharma Sales Breakdown by Application (2018-2024)
4.3.2 Europe Bio-pharma Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Bio-pharma Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Bio-pharma Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Bio-pharma Sales Breakdown by Application (2018-2024)
5 North America Bio-pharma by Country
5.1 North America Bio-pharma Historic Market Size by Country
5.1.1 North America Bio-pharma Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Bio-pharma Sales in Volume by Country (2018-2024)
5.1.3 North America Bio-pharma Sales in Value by Country (2018-2024)
5.2 North America Bio-pharma Forecasted Market Size by Country
5.2.1 North America Bio-pharma Sales in Volume by Country (2024-2034)
5.2.2 North America Bio-pharma Sales in Value by Country (2024-2034)
6 Europe Bio-pharma by Country
6.1 Europe Bio-pharma Historic Market Size by Country
6.1.1 Europe Bio-pharma Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Bio-pharma Sales in Volume by Country (2018-2024)
6.1.3 Europe Bio-pharma Sales in Value by Country (2018-2024)
6.2 Europe Bio-pharma Forecasted Market Size by Country
6.2.1 Europe Bio-pharma Sales in Volume by Country (2024-2034)
6.2.2 Europe Bio-pharma Sales in Value by Country (2024-2034)
7 Asia-Pacific Bio-pharma by Region
7.1 Asia-Pacific Bio-pharma Historic Market Size by Region
7.1.1 Asia-Pacific Bio-pharma Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Bio-pharma Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Bio-pharma Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Bio-pharma Forecasted Market Size by Region
7.2.1 Asia-Pacific Bio-pharma Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Bio-pharma Sales in Value by Region (2024-2034)
8 Latin America Bio-pharma by Country
8.1 Latin America Bio-pharma Historic Market Size by Country
8.1.1 Latin America Bio-pharma Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Bio-pharma Sales in Volume by Country (2018-2024)
8.1.3 Latin America Bio-pharma Sales in Value by Country (2018-2024)
8.2 Latin America Bio-pharma Forecasted Market Size by Country
8.2.1 Latin America Bio-pharma Sales in Volume by Country (2024-2034)
8.2.2 Latin America Bio-pharma Sales in Value by Country (2024-2034)
9 Middle East and Africa Bio-pharma by Country
9.1 Middle East and Africa Bio-pharma Historic Market Size by Country
9.1.1 Middle East and Africa Bio-pharma Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Bio-pharma Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Bio-pharma Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Bio-pharma Forecasted Market Size by Country
9.2.1 Middle East and Africa Bio-pharma Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Bio-pharma Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Bio-pharma Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Pfizer Bio-pharma Products Offered
10.1.5 Pfizer Recent Development
10.2 F. Hoffmann-La Roche AG
10.2.1 F. Hoffmann-La Roche AG Company Information
10.2.2 F. Hoffmann-La Roche AG Introduction and Business Overview
10.2.3 F. Hoffmann-La Roche AG Bio-pharma Sales, Revenue and Gross Margin (2018-2024)
10.2.4 F. Hoffmann-La Roche AG Bio-pharma Products Offered
10.2.5 F. Hoffmann-La Roche AG Recent Development
10.3 Johnson & Johnson Services
10.3.1 Johnson & Johnson Services Company Information
10.3.2 Johnson & Johnson Services Introduction and Business Overview
10.3.3 Johnson & Johnson Services Bio-pharma Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Johnson & Johnson Services Bio-pharma Products Offered
10.3.5 Johnson & Johnson Services Recent Development
10.4 Sanofi, Amgen
10.4.1 Sanofi, Amgen Company Information
10.4.2 Sanofi, Amgen Introduction and Business Overview
10.4.3 Sanofi, Amgen Bio-pharma Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Sanofi, Amgen Bio-pharma Products Offered
10.4.5 Sanofi, Amgen Recent Development
10.5 AbbVie
10.5.1 AbbVie Company Information
10.5.2 AbbVie Introduction and Business Overview
10.5.3 AbbVie Bio-pharma Sales, Revenue and Gross Margin (2018-2024)
10.5.4 AbbVie Bio-pharma Products Offered
10.5.5 AbbVie Recent Development
10.6 Merck & Co., Inc
10.6.1 Merck & Co., Inc Company Information
10.6.2 Merck & Co., Inc Introduction and Business Overview
10.6.3 Merck & Co., Inc Bio-pharma Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Merck & Co., Inc Bio-pharma Products Offered
10.6.5 Merck & Co., Inc Recent Development
10.7 Biogen Idec
10.7.1 Biogen Idec Company Information
10.7.2 Biogen Idec Introduction and Business Overview
10.7.3 Biogen Idec Bio-pharma Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Biogen Idec Bio-pharma Products Offered
10.7.5 Biogen Idec Recent Development
10.8 Bayer AG
10.8.1 Bayer AG Company Information
10.8.2 Bayer AG Introduction and Business Overview
10.8.3 Bayer AG Bio-pharma Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Bayer AG Bio-pharma Products Offered
10.8.5 Bayer AG Recent Development
10.9 Eli Lilly and Company
10.9.1 Eli Lilly and Company Company Information
10.9.2 Eli Lilly and Company Introduction and Business Overview
10.9.3 Eli Lilly and Company Bio-pharma Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Eli Lilly and Company Bio-pharma Products Offered
10.9.5 Eli Lilly and Company Recent Development
10.10 Novartis AG GlaxoSmithKline Plc
10.10.1 Novartis AG GlaxoSmithKline Plc Company Information
10.10.2 Novartis AG GlaxoSmithKline Plc Introduction and Business Overview
10.10.3 Novartis AG GlaxoSmithKline Plc Bio-pharma Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Novartis AG GlaxoSmithKline Plc Bio-pharma Products Offered
10.10.5 Novartis AG GlaxoSmithKline Plc Recent Development
10.11 Bristol-Myers Squibb Company
10.11.1 Bristol-Myers Squibb Company Company Information
10.11.2 Bristol-Myers Squibb Company Introduction and Business Overview
10.11.3 Bristol-Myers Squibb Company Bio-pharma Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Bristol-Myers Squibb Company Bio-pharma Products Offered
10.11.5 Bristol-Myers Squibb Company Recent Development
10.12 AstraZeneca PLC
10.12.1 AstraZeneca PLC Company Information
10.12.2 AstraZeneca PLC Introduction and Business Overview
10.12.3 AstraZeneca PLC Bio-pharma Sales, Revenue and Gross Margin (2018-2024)
10.12.4 AstraZeneca PLC Bio-pharma Products Offered
10.12.5 AstraZeneca PLC Recent Development
10.13 Abbott Laboratories
10.13.1 Abbott Laboratories Company Information
10.13.2 Abbott Laboratories Introduction and Business Overview
10.13.3 Abbott Laboratories Bio-pharma Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Abbott Laboratories Bio-pharma Products Offered
10.13.5 Abbott Laboratories Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Bio-pharma Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Bio-pharma Industrial Chain Analysis
11.4 Bio-pharma Market Dynamics
11.4.1 Bio-pharma Industry Trends
11.4.2 Bio-pharma Market Drivers
11.4.3 Bio-pharma Market Challenges
11.4.4 Bio-pharma Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Bio-pharma Distributors
12.3 Bio-pharma Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Monoclonal Antibodies
Table 2. Major Company of Recombinant Proteins
Table 3. Major Company of Granulocyte-Colony Stimulating Factor (G-CSF)
Table 4. Major Company of Interferons
Table 5. Major Company of Recombinant Human Insulin
Table 6. Major Company of Erythropoietin
Table 7. Major Company of Vaccines
Table 8. Major Company of Growth Hormones
Table 9. Major Company of Purified Proteins
Table 10. Major Company of Others
Table 11. Global Bio-pharma Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 12. Global Bio-pharma Sales by Type (2018-2024) & (K Pcs)
Table 13. Global Bio-pharma Sales Market Share in Volume by Type (2018-2024)
Table 14. Global Bio-pharma Sales by Type (2018-2024) & (US& Million)
Table 15. Global Bio-pharma Market Share in Value by Type (2018-2024)
Table 16. Global Bio-pharma Price by Type (2018-2024) & (USD/Pcs)
Table 17. Global Bio-pharma Sales by Type (2024-2034) & (K Pcs)
Table 18. Global Bio-pharma Sales Market Share in Volume by Type (2024-2034)
Table 19. Global Bio-pharma Sales by Type (2024-2034) & (US$ Million)
Table 20. Global Bio-pharma Sales Market Share in Value by Type (2024-2034)
Table 21. Global Bio-pharma Price by Type (2024-2034) & (USD/Pcs)
Table 22. North America Bio-pharma Sales by Type (2018-2024) & (K Pcs)
Table 23. North America Bio-pharma Sales by Type (2018-2024) & (US$ Million)
Table 24. Europe Bio-pharma Sales (K Pcs) by Type (2018-2024)
Table 25. Europe Bio-pharma Sales by Type (2018-2024) & (US$ Million)
Table 26. Asia-Pacific Bio-pharma Sales (K Pcs) by Type (2018-2024)
Table 27. Asia-Pacific Bio-pharma Sales by Type (2018-2024) & (US$ Million)
Table 28. Latin America Bio-pharma Sales (K Pcs) by Type (2018-2024)
Table 29. Latin America Bio-pharma Sales by Type (2018-2024) & (US$ Million)
Table 30. Middle East and Africa Bio-pharma Sales (K Pcs) by Type (2018-2024)
Table 31. Middle East and Africa Bio-pharma Sales by Type (2018-2024) & (US$ Million)
Table 32. Global Bio-pharma Sales by Company (2018-2024) & (K Pcs)
Table 33. Global Bio-pharma Sales Share by Company (2018-2024)
Table 34. Global Bio-pharma Revenue by Company (2018-2024) & (US$ Million)
Table 35. Global Bio-pharma Revenue Share by Company (2018-2024)
Table 36. Global Market Bio-pharma Price by Company (2018-2024) & (USD/Pcs)
Table 37. Global Bio-pharma Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 38. Global Bio-pharma Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 39. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Bio-pharma as of 2022)
Table 40. Date of Key Manufacturers Enter into Bio-pharma Market
Table 41. Key Manufacturers Bio-pharma Product Type
Table 42. Mergers & Acquisitions, Expansion Plans
Table 43. Global Bio-pharma Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 44. Global Bio-pharma Sales by Region (2018-2024) & (K Pcs)
Table 45. Global Bio-pharma Sales Market Share in Volume by Region (2018-2024)
Table 46. Global Bio-pharma Sales by Region (2018-2024) & (US$ Million)
Table 47. Global Bio-pharma Sales Market Share in Value by Region (2018-2024)
Table 48. Global Bio-pharma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 49. Global Bio-pharma Sales by Region (2024-2034) & (K Pcs)
Table 50. Global Bio-pharma Sales Market Share in Volume by Region (2024-2034)
Table 51. Global Bio-pharma Sales by Region (2024-2034) & (US$ Million)
Table 52. Global Bio-pharma Sales Market Share in Value by Region (2024-2034)
Table 53. Global Bio-pharma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 54. Global Bio-pharma Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 55. Global Bio-pharma Sales by Application (2018-2024) & (K Pcs)
Table 56. Global Bio-pharma Sales Market Share in Volume by Application (2018-2024)
Table 57. Global Bio-pharma Sales by Application (2018-2024) & (US$ Million)
Table 58. Global Bio-pharma Sales Market Share in Value by Application (2018-2024)
Table 59. Global Bio-pharma Price by Application (2018-2024) & (USD/Pcs)
Table 60. Global Bio-pharma Sales by Application (2024-2034) & (K Pcs)
Table 61. Global Bio-pharma Sales Market Share in Volume by Application (2024-2034)
Table 62. Global Bio-pharma Sales by Application (2024-2034) & (US$ Million)
Table 63. Global Bio-pharma Sales Market Share in Value by Application (2024-2034)
Table 64. Global Bio-pharma Price by Application (2024-2034) & (USD/Pcs)
Table 65. North America Bio-pharma Sales by Application (2018-2024) (K Pcs)
Table 66. North America Bio-pharma Sales by Application (2018-2024) & (US$ Million)
Table 67. Europe Bio-pharma Sales by Application (2018-2024) (K Pcs)
Table 68. Europe Bio-pharma Sales by Application (2018-2024) & (US$ Million)
Table 69. Asia-Pacific Bio-pharma Sales by Application (2018-2024) (K Pcs)
Table 70. Asia-Pacific Bio-pharma Sales by Application (2018-2024) & (US$ Million)
Table 71. Latin America Bio-pharma Sales by Application (2018-2024) (K Pcs)
Table 72. Latin America Bio-pharma Sales by Application (2018-2024) & (US$ Million)
Table 73. Middle East and Africa Bio-pharma Sales by Application (2018-2024) (K Pcs)
Table 74. Middle East and Africa Bio-pharma Sales by Application (2018-2024) & (US$ Million)
Table 75. North America Bio-pharma Sales by Country (2018-2024) & (K Pcs)
Table 76. North America Bio-pharma Sales Market Share in Volume by Country (2018-2024)
Table 77. North America Bio-pharma Sales by Country (2018-2024) & (US$ Million)
Table 78. North America Bio-pharma Sales Market Share in Value by Country (2018-2024)
Table 79. North America Bio-pharma Sales by Country (2024-2034) & (K Pcs)
Table 80. North America Bio-pharma Sales Market Share in Volume by Country (2024-2034)
Table 81. North America Bio-pharma Sales by Country (2024-2034) & (US$ Million)
Table 82. North America Bio-pharma Sales Market Share in Value by Country (2024-2034)
Table 83. Europe Bio-pharma Sales by Country (2018-2024) & (K Pcs)
Table 84. Europe Bio-pharma Sales Market Share in Volume by Country (2018-2024)
Table 85. Europe Bio-pharma Sales by Country (2018-2024) & (US$ Million)
Table 86. Europe Bio-pharma Sales Market Share in Value by Country (2018-2024)
Table 87. Europe Bio-pharma Sales by Country (2024-2034) & (K Pcs)
Table 88. Europe Bio-pharma Sales Market Share in Volume by Country (2024-2034)
Table 89. Europe Bio-pharma Sales by Country (2024-2034) & (US$ Million)
Table 90. Europe Bio-pharma Sales Market Share in Value by Country (2024-2034)
Table 91. Asia-Pacific Bio-pharma Sales by Region (2018-2024) & (K Pcs)
Table 92. Asia-Pacific Bio-pharma Sales Market Share in Volume by Region (2018-2024)
Table 93. Asia-Pacific Bio-pharma Sales by Region (2018-2024) & (US$ Million)
Table 94. Asia-Pacific Bio-pharma Sales Market Share in Value by Region (2018-2024)
Table 95. Asia-Pacific Bio-pharma Sales by Region (2024-2034) & (K Pcs)
Table 96. Asia-Pacific Bio-pharma Sales Market Share in Volume by Region (2024-2034)
Table 97. Asia-Pacific Bio-pharma Sales by Region (2024-2034) & (US$ Million)
Table 98. Asia-Pacific Bio-pharma Sales Market Share in Value by Region (2024-2034)
Table 99. Latin America Bio-pharma Sales by Country (2018-2024) & (K Pcs)
Table 100. Latin America Bio-pharma Sales Market Share in Volume by Country (2018-2024)
Table 101. Latin America Bio-pharma Sales by Country (2018-2024) & (US$ Million)
Table 102. Latin America Bio-pharma Sales Market Share in Value by Country (2018-2024)
Table 103. Latin America Bio-pharma Sales by Country (2024-2034) & (K Pcs)
Table 104. Latin America Bio-pharma Sales Market Share in Volume by Country (2024-2034)
Table 105. Latin America Bio-pharma Sales by Country (2024-2034) & (US$ Million)
Table 106. Latin America Bio-pharma Sales Market Share in Value by Country (2024-2034)
Table 107. Middle East and Africa Bio-pharma Sales by Country (2018-2024) & (K Pcs)
Table 108. Middle East and Africa Bio-pharma Sales Market Share in Volume by Country (2018-2024)
Table 109. Middle East and Africa Bio-pharma Sales by Country (2018-2024) & (US$ Million)
Table 110. Middle East and Africa Bio-pharma Sales Market Share in Value by Country (2018-2024)
Table 111. Middle East and Africa Bio-pharma Sales by Country (2024-2034) & (K Pcs)
Table 112. Middle East and Africa Bio-pharma Sales Market Share in Volume by Country (2024-2034)
Table 113. Middle East and Africa Bio-pharma Sales by Country (2024-2034) & (US$ Million)
Table 114. Middle East and Africa Bio-pharma Sales Market Share in Value by Country (2024-2034)
Table 115. Pfizer Company Information
Table 116. Pfizer Introduction and Business Overview
Table 117. Pfizer Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 118. Pfizer Bio-pharma Product
Table 119. Pfizer Recent Development
Table 120. F. Hoffmann-La Roche AG Company Information
Table 121. F. Hoffmann-La Roche AG Introduction and Business Overview
Table 122. F. Hoffmann-La Roche AG Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 123. F. Hoffmann-La Roche AG Bio-pharma Product
Table 124. F. Hoffmann-La Roche AG Recent Development
Table 125. Johnson & Johnson Services Company Information
Table 126. Johnson & Johnson Services Introduction and Business Overview
Table 127. Johnson & Johnson Services Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 128. Johnson & Johnson Services Bio-pharma Product
Table 129. Johnson & Johnson Services Recent Development
Table 130. Sanofi, Amgen Company Information
Table 131. Sanofi, Amgen Introduction and Business Overview
Table 132. Sanofi, Amgen Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 133. Sanofi, Amgen Bio-pharma Product
Table 134. Sanofi, Amgen Recent Development
Table 135. AbbVie Company Information
Table 136. AbbVie Introduction and Business Overview
Table 137. AbbVie Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 138. AbbVie Bio-pharma Product
Table 139. AbbVie Recent Development
Table 140. Merck & Co., Inc Company Information
Table 141. Merck & Co., Inc Introduction and Business Overview
Table 142. Merck & Co., Inc Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 143. Merck & Co., Inc Bio-pharma Product
Table 144. Merck & Co., Inc Recent Development
Table 145. Biogen Idec Company Information
Table 146. Biogen Idec Introduction and Business Overview
Table 147. Biogen Idec Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 148. Biogen Idec Bio-pharma Product
Table 149. Biogen Idec Recent Development
Table 150. Bayer AG Company Information
Table 151. Bayer AG Introduction and Business Overview
Table 152. Bayer AG Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 153. Bayer AG Bio-pharma Product
Table 154. Bayer AG Recent Development
Table 155. Eli Lilly and Company Company Information
Table 156. Eli Lilly and Company Introduction and Business Overview
Table 157. Eli Lilly and Company Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 158. Eli Lilly and Company Bio-pharma Product
Table 159. Eli Lilly and Company Recent Development
Table 160. Novartis AG GlaxoSmithKline Plc Company Information
Table 161. Novartis AG GlaxoSmithKline Plc Introduction and Business Overview
Table 162. Novartis AG GlaxoSmithKline Plc Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 163. Novartis AG GlaxoSmithKline Plc Bio-pharma Product
Table 164. Novartis AG GlaxoSmithKline Plc Recent Development
Table 165. Bristol-Myers Squibb Company Company Information
Table 166. Bristol-Myers Squibb Company Introduction and Business Overview
Table 167. Bristol-Myers Squibb Company Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 168. Bristol-Myers Squibb Company Bio-pharma Product
Table 169. Bristol-Myers Squibb Company Recent Development
Table 170. AstraZeneca PLC Company Information
Table 171. AstraZeneca PLC Introduction and Business Overview
Table 172. AstraZeneca PLC Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 173. AstraZeneca PLC Bio-pharma Product
Table 174. AstraZeneca PLC Recent Development
Table 175. Abbott Laboratories Company Information
Table 176. Abbott Laboratories Introduction and Business Overview
Table 177. Abbott Laboratories Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 178. Abbott Laboratories Bio-pharma Product
Table 179. Abbott Laboratories Recent Development
Table 180. Key Raw Materials Lists
Table 181. Raw Materials Key Suppliers Lists
Table 182. Bio-pharma Market Trends
Table 183. Bio-pharma Market Drivers
Table 184. Bio-pharma Market Challenges
Table 185. Bio-pharma Market Restraints
Table 186. Bio-pharma Distributors List
Table 187. Bio-pharma Downstream Customers
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
List of Figures
Figure 1. Bio-pharma Product Picture
Figure 2. Global Bio-pharma Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Bio-pharma Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Bio-pharma Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of Monoclonal Antibodies
Figure 6. Global Monoclonal Antibodies Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of Recombinant Proteins
Figure 8. Global Recombinant Proteins Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of Granulocyte-Colony Stimulating Factor (G-CSF)
Figure 10. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Product Picture of Interferons
Figure 12. Global Interferons Sales YoY Growth (2018-2034) & (K Pcs)
Figure 13. Product Picture of Recombinant Human Insulin
Figure 14. Global Recombinant Human Insulin Sales YoY Growth (2018-2034) & (K Pcs)
Figure 15. Product Picture of Erythropoietin
Figure 16. Global Erythropoietin Sales YoY Growth (2018-2034) & (K Pcs)
Figure 17. Product Picture of Vaccines
Figure 18. Global Vaccines Sales YoY Growth (2018-2034) & (K Pcs)
Figure 19. Product Picture of Growth Hormones
Figure 20. Global Growth Hormones Sales YoY Growth (2018-2034) & (K Pcs)
Figure 21. Product Picture of Purified Proteins
Figure 22. Global Purified Proteins Sales YoY Growth (2018-2034) & (K Pcs)
Figure 23. Product Picture of Others
Figure 24. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 25. Global Bio-pharma Sales by Type (2018-2034) & (US$ Million)
Figure 26. Global Bio-pharma Sales Market Share by Type in 2022 & 2034
Figure 27. North America Bio-pharma Sales Market Share in Volume by Type in 2022
Figure 28. North America Bio-pharma Sales Market Share in Value by Type in 2022
Figure 29. Europe Bio-pharma Sales Market Share in Volume by Type in 2022
Figure 30. Europe Bio-pharma Sales Market Share in Value by Type in 2022
Figure 31. Asia-Pacific Bio-pharma Sales Market Share in Volume by Type in 2022
Figure 32. Asia-Pacific Bio-pharma Sales Market Share in Value by Type in 2022
Figure 33. Latin America Bio-pharma Sales Market Share in Volume by Type in 2022
Figure 34. Latin America Bio-pharma Sales Market Share in Value by Type in 2022
Figure 35. Middle East and Africa Bio-pharma Sales Market Share in Volume by Type in 2022
Figure 36. Middle East and Africa Bio-pharma Sales Market Share in Value by Type in 2022
Figure 37. The 5 and 10 Largest Manufacturers in the World: Market Share by Bio-pharma Sales in 2022
Figure 38. The 5 and 10 Largest Manufacturers in the World: Market Share by Bio-pharma Revenue in 2022
Figure 39. Bio-pharma Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 40. Product Picture of Metabolic Disorders
Figure 41. Global Metabolic Disorders Sales YoY Growth (2018-2034) & (K Pcs)
Figure 42. Product Picture of Oncology
Figure 43. Global Oncology Sales YoY Growth (2018-2034) & (K Pcs)
Figure 44. Product Picture of Neurological Disorders
Figure 45. Global Neurological Disorders Sales YoY Growth (2018-2034) & (K Pcs)
Figure 46. Product Picture of Cardiovascular Diseases
Figure 47. Global Cardiovascular Diseases Sales YoY Growth (2018-2034) & (K Pcs)
Figure 48. Product Picture of Inflammatory and Infectious Diseases
Figure 49. Global Inflammatory and Infectious Diseases Sales YoY Growth (2018-2034) & (K Pcs)
Figure 50. Product Picture of Others
Figure 51. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 52. Global Bio-pharma Sales by Application (2018-2034) & (US$ Million)
Figure 53. Global Bio-pharma Sales Market Share by Application in 2022 & 2034
Figure 54. North America Bio-pharma Sales Market Share in Volume by Application in 2022
Figure 55. North America Bio-pharma Sales Market Share in Value by Application in 2022
Figure 56. Europe Bio-pharma Sales Market Share in Volume by Application in 2022
Figure 57. Europe Bio-pharma Sales Market Share in Value by Application in 2022
Figure 58. Asia-Pacific Bio-pharma Sales Market Share in Volume by Application in 2022
Figure 59. Asia-Pacific Bio-pharma Sales Market Share in Value by Application in 2022
Figure 60. Latin America Bio-pharma Sales Market Share in Volume by Application in 2022
Figure 61. Latin America Bio-pharma Sales Market Share in Value by Application in 2022
Figure 62. Middle East and Africa Bio-pharma Sales Market Share in Value by Application in 2022
Figure 63. Key Raw Materials Price
Figure 64. Bio-pharma Manufacturing Cost Structure
Figure 65. Bio-pharma Industrial Chain Analysis
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed